Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [EGFR inhibition in NSCLC tumor cell lines : Influence on cell cycle and tumor control].

× No keyword cloud information.

9 in total

Review 1. Contribution of the immune system to bystander and non-targeted effects of ionizing radiation.

Authors: Franz Rödel; Benjamin Frey; Gabriele Multhoff; Udo Gaipl
Journal: Cancer Lett Date: 2013-10-15 Impact factor: 8.679

2. p53-Dependent accelerated senescence induced by ionizing radiation in breast tumour cells.

Authors: K R Jones; L W Elmore; C Jackson-Cook; G Demasters; L F Povirk; S E Holt; D A Gewirtz
Journal: Int J Radiat Biol Date: 2005-06 Impact factor: 2.694

3. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.

Authors: Jordi Giralt; Jose Trigo; Sandra Nuyts; Mahmut Ozsahin; Krzysztof Skladowski; Georges Hatoum; Jean-Francois Daisne; Alejandro César Yunes Ancona; Anthony Cmelak; Ricard Mesía; Alicia Zhang; Kelly S Oliner; Ari VanderWalde
Journal: Lancet Oncol Date: 2015-01-15 Impact factor: 41.316

4. Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol.

Authors: Katsuyuki Hotta; Jiichiro Sasaki; Sho Saeki; Nagio Takigawa; Kuniaki Katsui; Koichi Takayama; Naoyuki Nogami; Yoshiyuki Shioyama; Akihiro Bessho; Junji Kishimoto; Mitsune Tanimoto; Katsuyuki Kiura; Yukito Ichinose
Journal: Clin Lung Cancer Date: 2015-08-18 Impact factor: 4.785

Review 5. Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.

Authors: Teresa Troiani; Silvia Zappavigna; Erika Martinelli; Santolo R Addeo; Paola Stiuso; Fortunato Ciardiello; Michele Caraglia
Journal: Expert Opin Biol Ther Date: 2013-01-03 Impact factor: 4.388

6. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Authors: James A Bonner; Paul M Harari; Jordi Giralt; Roger B Cohen; Christopher U Jones; Ranjan K Sur; David Raben; Jose Baselga; Sharon A Spencer; Junming Zhu; Hagop Youssoufian; Eric K Rowinsky; K Kian Ang
Journal: Lancet Oncol Date: 2009-11-10 Impact factor: 41.316

Review 7. Inflammation and cancer: advances and new agents.

Authors: Shanthini M Crusz; Frances R Balkwill
Journal: Nat Rev Clin Oncol Date: 2015-06-30 Impact factor: 66.675

8. Dying cell clearance and its impact on the outcome of tumor radiotherapy.

Authors: Kirsten Lauber; Anne Ernst; Michael Orth; Martin Herrmann; Claus Belka
Journal: Front Oncol Date: 2012-09-11 Impact factor: 6.244

9. The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs.

Authors: Yanna Tang; Wenfeng Fang; Yaxiong Zhang; Shaodong Hong; Shiyang Kang; Yue Yan; Nan Chen; Jianhua Zhan; Xiaobo He; Tao Qin; Ge Li; Wenyi Tang; Peijian Peng; Li Zhang
Journal: Oncotarget Date: 2015-06-10

9 in total